Therapeutic Hepatitis C Virus Vaccine

Clinical trial NCT04318379 · UNKNOWN

Trial details

NCT number: NCT04318379
Sponsor: GeneCure Biotechnologies
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis C Infection

Start date: 2021-04-20
Primary completion: 2023-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.